There's nothing better than buying a couple of S&P/ASX 200 Index (ASX: XJO) shares nice and early on their upward curve.
You may have bought later than the bottom, but that's a small premium to pay for reduced risk that the business will tank.
Here are two such boom stocks that Medallion Financial Group private client advisor Stuart Bromley reckons is not too late to buy:
Image source: Getty Images
Low gearing to combat high interest rates
Goodman Group (ASX: GMG) shares have rocketed 6% since 10 July.
Although real estate is battered after the recent interest rate hikes, Bromley points to how Goodman has all the right levers in place for growth in the long run.
"This global industrial property giant has an occupancy rate of 99%, with quality long-term tenants," Bromley told The Bull.
"The company continues to build for the future, with $13.9 billion of projects in the pipeline."
He also reminded investors that the industrial property group isn't affected by higher interest costs as much as some other landlords.
"Particularly encouraging in the near term is the company's low gearing levels in this high interest rate environment."
It seems the wider professional community is largely in agreement with Bromley.
According to CMC Markets, an amazing 10 out of 13 analysts currently rate Goodman shares as a buy. Nine of those classify it as a strong buy.
'Strong revenue figures can be sustained'
The Polynovo Ltd (ASX: PNV) share price is up 12.9% since 7 July.
Bromley noted how well the biotechnology business is doing at the moment.
"PolyNovo has continued to set month-on-month sales records with its biodegradable skin regeneration product."
But it's not just a temporary rush, he added.
"We're confident strong revenue figures can be sustained into upcoming results given continuing investment in its US sales force."
Polynovo is also in positive financial health.
"A capital raising late last year has left the company with a stronger balance sheet."
Bromley's peers are less unanimous about this pick.
While three analysts covering the stock reckon it's a strong buy on CMC Markets, two others have rated it a sell.
